159 related articles for article (PubMed ID: 35523105)
1. Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples.
Berengua C; López M; Esteban M; Marín P; Ramos P; Cuerpo MD; Gich I; Navarro F; Miró E; Rabella N
J Clin Virol; 2022 Jul; 152():105167. PubMed ID: 35523105
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.
Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G
Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922
[TBL] [Abstract][Full Text] [Related]
3. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
Bullard J; Dust K; Funk D; Strong JE; Alexander D; Garnett L; Boodman C; Bello A; Hedley A; Schiffman Z; Doan K; Bastien N; Li Y; Van Caeseele PG; Poliquin G
Clin Infect Dis; 2020 Dec; 71(10):2663-2666. PubMed ID: 32442256
[TBL] [Abstract][Full Text] [Related]
4. Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse-transcription polymerase chain reaction: A systematic review and meta-analysis.
Fomenko A; Weibel S; Moezi H; Menger K; Schmucker C; Metzendorf MI; Motschall E; Falcone V; Huzly D; Panning M; Rücker G; Hengel H
Rev Med Virol; 2022 Sep; 32(5):e2342. PubMed ID: 35366033
[TBL] [Abstract][Full Text] [Related]
5. Infectivity assay for detection of SARS-CoV-2 in samples from patients with COVID-19.
Hiroi S; Kubota-Koketsu R; Sasaki T; Morikawa S; Motomura K; Nakayama EE; Okuno Y; Shioda T
J Med Virol; 2021 Oct; 93(10):5917-5923. PubMed ID: 34139026
[TBL] [Abstract][Full Text] [Related]
6. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
[TBL] [Abstract][Full Text] [Related]
7. An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
Virol J; 2021 Apr; 18(1):71. PubMed ID: 33827618
[TBL] [Abstract][Full Text] [Related]
8. Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review.
Jefferson T; Spencer EA; Conly JM; Rosca EC; Maltoni S; Brassey J; Onakpoya IJ; Evans DH; Heneghan CJ; Plüddemann A
J Hosp Infect; 2023 Feb; 132():62-72. PubMed ID: 36473552
[TBL] [Abstract][Full Text] [Related]
9. Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.
Basile K; McPhie K; Carter I; Alderson S; Rahman H; Donovan L; Kumar S; Tran T; Ko D; Sivaruban T; Ngo C; Toi C; O'Sullivan MV; Sintchenko V; Chen SC; Maddocks S; Dwyer DE; Kok J
Clin Infect Dis; 2021 Nov; 73(9):e2952-e2959. PubMed ID: 33098412
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
Santos Bravo M; Nicolás D; Berengua C; Fernandez M; Hurtado JC; Tortajada M; Barroso S; Vilella A; Mosquera MM; Vila J; Marcos MA
J Infect Dis; 2021 Oct; 224(8):1325-1332. PubMed ID: 34329473
[TBL] [Abstract][Full Text] [Related]
11. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
Yamada S; Fukushi S; Kinoshita H; Ohnishi M; Suzuki T; Fujimoto T; Saijo M; Maeda K;
BMJ Open Respir Res; 2021 Feb; 8(1):. PubMed ID: 33627333
[TBL] [Abstract][Full Text] [Related]
12. Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples.
Bruce EA; Mills MG; Sampoleo R; Perchetti GA; Huang ML; Despres HW; Schmidt MM; Roychoudhury P; Shirley DJ; Jerome KR; Greninger AL; Botten JW
EMBO Mol Med; 2022 Feb; 14(2):e15290. PubMed ID: 34862752
[TBL] [Abstract][Full Text] [Related]
13. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity.
Santos Bravo M; Berengua C; Marín P; Esteban M; Rodriguez C; Del Cuerpo M; Miró E; Cuesta G; Mosquera M; Sánchez-Palomino S; Vila J; Rabella N; Marcos MÁ
J Clin Microbiol; 2022 Jan; 60(1):e0160921. PubMed ID: 34669457
[TBL] [Abstract][Full Text] [Related]
14. Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
Woudenberg T; Eberle U; Marosevic D; Liebl B; Ackermann N; Katz K; Sing A;
Epidemiol Infect; 2021 Jun; 149():e150. PubMed ID: 34158139
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
[TBL] [Abstract][Full Text] [Related]
16. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
[TBL] [Abstract][Full Text] [Related]
17. Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study.
Dzieciolowska S; Charest H; Roy T; Fafard J; Carazo S; Levade I; Longtin J; Parkes L; Beaulac SN; Villeneuve J; Savard P; Corbeil J; De Serres G; Longtin Y
Clin Infect Dis; 2024 Mar; 78(3):613-624. PubMed ID: 37675577
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.
Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P
Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective analysis of the performance of the SARS-CoV-2 rapid antigen detection test compared to the reference RT-PCR test].
Bernard M; Cosentino G; Pieri L; Zachary P; Buser M; Kbaier L; Giannoli JM
Ann Biol Clin (Paris); 2021 Apr; 79(2):168-175. PubMed ID: 33985935
[TBL] [Abstract][Full Text] [Related]
20. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
Folgueira MD; Luczkowiak J; Lasala F; Pérez-Rivilla A; Delgado R
Clin Microbiol Infect; 2021 Jun; 27(6):886-891. PubMed ID: 33631334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
